Scinovex
article Open AccessTop 1% cited

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

Diabetologia · 2016 · Vol. 59(6) · pp. 1121–1140
Liver Disease Diagnosis and TreatmentDiet, Metabolism, and DiseaseLiver Disease and TransplantationMedicineFatty liverDiseaseAlcoholic liver diseaseHuman physiologyDiabetes mellitusClinical PracticeInternal medicineIntensive care medicineEndocrinology

MeSH terms

LiraglutidePioglitazoneHumansLiverRisk FactorsThiazolidinedionesNon-alcoholic Fatty Liver Disease

Funding

  • Abbott Laboratories
  • Eli Lilly and Company
  • AstraZeneca
  • Sanofi
  • Gilead Sciences
  • Novo Nordisk
  • Università degli Studi di Torino
  • Novartis Pharma
Citations
667
FWCI
27.89
field-weighted impact
References
149
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.